Home Trials Current Trials TEMPO-2: TNK-tPA for Minor Ischemic Stroke with Proven Acute Symptomatic Occlusion Trial 2

TEMPO-2: TNK-tPA for Minor Ischemic Stroke with Proven Acute Symptomatic Occlusion Trial 2

E-mail Print PDF

Lead PI: Dr Shelagh B Coutts

Status: Recruiting

No. of Patients Currently Recruited: 139                                 No. of Patients Required: 1274

TEMPO-2 is examining the role of thrombolysis with low-dose (0.25mg/kg) tenecteplase for patients with minor stroke (NIHSS 0-5) and proven intracranial occlusion (defined by CTA or CTP) in reducing disability at 90 days after stroke onset. The study will enrol up to 1274 patients in Canada, Europe and Australia.

Trial URL: 

https://clinicaltrials.gov/ct2/show/NCT02398656?term=TEMPO&cond=stroke&rank=1

NCT02398656

Last Updated ( Thursday, 25 January 2018 16:05 )  


ASTN Latest news

Top Views